ZA846485B - 3-(piperidinyl)-and 3-(pyrrolidinyl)-1h-indazoles,a process for their preparation and their use as a medicament - Google Patents
3-(piperidinyl)-and 3-(pyrrolidinyl)-1h-indazoles,a process for their preparation and their use as a medicamentInfo
- Publication number
- ZA846485B ZA846485B ZA846485A ZA846485A ZA846485B ZA 846485 B ZA846485 B ZA 846485B ZA 846485 A ZA846485 A ZA 846485A ZA 846485 A ZA846485 A ZA 846485A ZA 846485 B ZA846485 B ZA 846485B
- Authority
- ZA
- South Africa
- Prior art keywords
- indazoles
- pyrrolidinyl
- piperidinyl
- medicament
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52508883A | 1983-08-22 | 1983-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA846485B true ZA846485B (en) | 1985-03-27 |
Family
ID=24091865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA846485A ZA846485B (en) | 1983-08-22 | 1984-08-21 | 3-(piperidinyl)-and 3-(pyrrolidinyl)-1h-indazoles,a process for their preparation and their use as a medicament |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0135781B1 (es) |
| JP (1) | JPS60100573A (es) |
| KR (1) | KR880002356B1 (es) |
| AT (1) | ATE47139T1 (es) |
| AU (1) | AU575846B2 (es) |
| CA (1) | CA1292232C (es) |
| DE (1) | DE3480091D1 (es) |
| DK (1) | DK400284A (es) |
| ES (2) | ES535289A0 (es) |
| FI (1) | FI82242C (es) |
| GR (1) | GR80160B (es) |
| HU (1) | HU198036B (es) |
| IL (1) | IL72743A (es) |
| NZ (1) | NZ209279A (es) |
| PH (1) | PH22032A (es) |
| PT (1) | PT79110B (es) |
| ZA (1) | ZA846485B (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0181793B1 (fr) * | 1984-10-16 | 1988-07-27 | Synthelabo | Dérivés de pipéridine, leur préparation et leur application en thérapeutique |
| EP0192935B1 (en) * | 1985-01-23 | 1991-02-27 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-(piperidinyl)-1h-indazoles a process for their preparation and their use as medicaments |
| US4999356A (en) * | 1987-08-07 | 1991-03-12 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-phenyl-3-(1-piperazinyl)-1H-indazoles |
| GB8811299D0 (en) * | 1988-05-12 | 1988-06-15 | Grayshan R | Indazole derivatives |
| NZ230045A (en) * | 1988-08-05 | 1990-11-27 | Janssen Pharmaceutica Nv | 3-piperazinylbenzazole derivatives and pharmaceutical compositions |
| US4957916A (en) * | 1988-08-05 | 1990-09-18 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
| US5015740A (en) * | 1988-08-05 | 1991-05-14 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| DE69021645T2 (de) * | 1989-05-19 | 1996-02-22 | Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. | N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. |
| US5561128A (en) * | 1989-05-19 | 1996-10-01 | Hoechst-Roussel Pharmaceuticals, Inc. | N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility |
| US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| US5364866A (en) | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| DK181190D0 (da) * | 1990-07-30 | 1990-07-30 | Lundbeck & Co As H | 3-aryl-indol- eller 3-aryl-indazolderivater |
| US5051430A (en) * | 1990-09-10 | 1991-09-24 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-(1H-indazol-3-yl)-4-pyridinamines |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| AU678186B2 (en) * | 1992-10-23 | 1997-05-22 | Merck Sharp & Dohme Limited | Dopamine receptor subtype ligands |
| WO1994010162A1 (en) * | 1992-10-23 | 1994-05-11 | Merck Sharp & Dohme Limited | Dopamine receptor subtype ligands |
| DE4414113A1 (de) * | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-Indolylpiperidine |
| US5668148A (en) * | 1995-04-20 | 1997-09-16 | Merck & Co., Inc. | Alpha1a adrenergic receptor antagonists |
| DE59713007D1 (de) | 1996-10-14 | 2009-06-25 | Bayer Healthcare Ag | Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen |
| FR2767827A1 (fr) * | 1997-09-03 | 1999-02-26 | Adir | Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| IL126745A (en) * | 1997-11-04 | 2003-09-17 | Pfizer Prod Inc | Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors |
| US6133290A (en) * | 1998-07-31 | 2000-10-17 | Eli Lilly And Company | 5-HT1F agonists |
| WO2004069828A1 (ja) * | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | ピペリジン化合物およびその医薬用途 |
| CA2551346A1 (en) * | 2003-12-31 | 2005-07-21 | Warner-Lambert Company Llc | N-substituted piperidine and piperazine derivatives |
| DK1828182T3 (da) | 2004-11-29 | 2010-05-10 | Warner Lambert Co | Terapeutiske pyrazol[3,4-B]pyridiner og indazoler |
| EP2350077B1 (en) * | 2008-10-14 | 2016-01-27 | Entasis Therapeutics Limited | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| DK2790687T3 (en) | 2011-12-16 | 2018-11-19 | Poseida Therapeutics Inc | TRPC4 MODULATORS FOR USE IN TREATMENT OR PREVENTION OF Pain |
| JP2015214492A (ja) * | 2012-09-07 | 2015-12-03 | 大日本住友製薬株式会社 | ３−（４−ピペリジル）−インダゾール誘導体 |
| ES2924359T3 (es) * | 2017-04-11 | 2022-10-06 | Sunshine Lake Pharma Co Ltd | Compuestos de indazol sustituidos con flúor y usos de los mismos |
-
1984
- 1984-08-15 HU HU843095A patent/HU198036B/hu not_active IP Right Cessation
- 1984-08-17 AT AT84109800T patent/ATE47139T1/de not_active IP Right Cessation
- 1984-08-17 EP EP84109800A patent/EP0135781B1/en not_active Expired
- 1984-08-17 DE DE8484109800T patent/DE3480091D1/de not_active Expired
- 1984-08-20 ES ES535289A patent/ES535289A0/es active Granted
- 1984-08-20 NZ NZ209279A patent/NZ209279A/en unknown
- 1984-08-20 FI FI843281A patent/FI82242C/fi not_active IP Right Cessation
- 1984-08-20 PH PH31122A patent/PH22032A/en unknown
- 1984-08-21 KR KR1019840005046A patent/KR880002356B1/ko not_active IP Right Cessation
- 1984-08-21 PT PT79110A patent/PT79110B/pt not_active IP Right Cessation
- 1984-08-21 AU AU32250/84A patent/AU575846B2/en not_active Ceased
- 1984-08-21 DK DK400284A patent/DK400284A/da not_active Application Discontinuation
- 1984-08-21 JP JP59172528A patent/JPS60100573A/ja active Granted
- 1984-08-21 CA CA000461452A patent/CA1292232C/en not_active Expired - Lifetime
- 1984-08-21 GR GR80160A patent/GR80160B/el unknown
- 1984-08-21 ZA ZA846485A patent/ZA846485B/xx unknown
- 1984-08-28 IL IL72743A patent/IL72743A/xx unknown
-
1985
- 1985-05-16 ES ES543206A patent/ES8603867A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPH051792B2 (es) | 1993-01-11 |
| HU198036B (en) | 1989-07-28 |
| PT79110A (en) | 1984-09-01 |
| AU575846B2 (en) | 1988-08-11 |
| FI843281A (fi) | 1985-02-23 |
| EP0135781A1 (en) | 1985-04-03 |
| ES543206A0 (es) | 1986-01-01 |
| IL72743A0 (en) | 1984-11-30 |
| NZ209279A (en) | 1988-05-30 |
| DE3480091D1 (en) | 1989-11-16 |
| FI843281A0 (fi) | 1984-08-20 |
| GR80160B (en) | 1984-12-19 |
| CA1292232C (en) | 1991-11-19 |
| ATE47139T1 (de) | 1989-10-15 |
| ES8601964A1 (es) | 1985-11-01 |
| DK400284D0 (da) | 1984-08-21 |
| IL72743A (en) | 1989-01-31 |
| FI82242C (fi) | 1991-02-11 |
| JPS60100573A (ja) | 1985-06-04 |
| FI82242B (fi) | 1990-10-31 |
| EP0135781B1 (en) | 1989-10-11 |
| AU3225084A (en) | 1985-02-28 |
| PT79110B (en) | 1986-09-15 |
| PH22032A (en) | 1988-05-13 |
| ES535289A0 (es) | 1985-11-01 |
| ES8603867A1 (es) | 1986-01-01 |
| KR850001748A (ko) | 1985-04-01 |
| HUT37139A (en) | 1985-11-28 |
| DK400284A (da) | 1985-02-23 |
| KR880002356B1 (ko) | 1988-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3480091D1 (en) | 3-(piperidinyl)- and 3-(pyrrolidinyl)-1h-indazoles, a process for their preparation and their use as a medicament | |
| DE3166231D1 (en) | Process for preparing 4-amino-2,2,6,6-tetramethylpiperidine | |
| CS38989A2 (en) | Method of phenoxyacetamidoderivative production | |
| ES8506293A1 (es) | Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles | |
| EP0127167A3 (en) | 3-(4-piperidinyl)-1,2-benzisothiazoles and derivates, a process for their preparation and their use as medicaments | |
| GR860571B (en) | Labdan-derivatives process for their preparation and their use as medicaments | |
| DE3172006D1 (en) | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof | |
| GR77706B (es) | ||
| DE3162735D1 (en) | Process for preparing 2,2,6,6-tetramethyl-4-piperidone | |
| GR77704B (es) | ||
| DE3064520D1 (en) | 3-(3'-amino-2'-hydroxy-n-prop-1'-oxy)-6-isopropylidenehydrazino-pyridazines, process for their production and medicaments containing them | |
| YU49079B (sh) | Novi derivati fosfolipida i postupak za njihovu proizvodnju | |
| ZW18590A1 (en) | Pyridylcarbamate compounds,process for preparing the same,and biocidal composition containing the same for controlling harmful organisms | |
| DE3064473D1 (en) | A process for preparing 3-beta-amino-4-beta-substituted 2-azetidinones and 3-(2,2-dihalogenovinyl)-imino-4-beta-substituted 2-azetidinone and 3-beta-(2,2-dihalogenovinyl)-amino-4-beta-substituted 2-azetidinone intermediates | |
| DE3262377D1 (en) | Novel nitrosourea derivative, process for preparing same and therapeutic composition containing said derivate | |
| DE3564201D1 (en) | Variable crown roll for machines for thermo-mechanical treatment | |
| ZA86465B (en) | 3-(piperidinyl)-and 3-(pyrrolidinyl)-1h-indazoles,a process for their preparation and their use as medicaments | |
| HU9201306D0 (en) | Process for the production of medical preparations for treating anxiety, containing r/+/-3-amino-1-hydroxy-pyrolydin-2-on | |
| JPS5597438A (en) | Treatment for titanium containing raw material |